Insider trade

UiPath (PATH): CEO sold ~$1.84M

Daniel Dines, CEO at UiPath, sold ~$1.84M of UiPath shares.

~$1.84M
Approx. value · 123K sh @ $14.99
859K
Holds after · shares reported
Traded
Oct 7, 2025
Filed
Oct 8, 2025

What stands out in this filing

  • The sale was 12.5% of the shares this insider held before it; the filing reports 859,138 shares, held indirectly afterwards.
  • 122,733 shares at an average of $14.99 each, as reported on the form.
  • Footnote references a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 10, 2025InsiderCEO sold ~$540K of PATH shares in the open market
  2. Sep 17, 2025InsiderCEO sold ~$1.44M of PATH shares in the open market
  3. Sep 18, 2025InsiderCEO sold ~$1.46M of PATH shares in the open market
  4. Sep 19, 2025InsiderCEO sold ~$1.46M of PATH shares in the open market
  5. Sep 22, 2025InsiderCEO sold ~$1.5M of PATH shares in the open market
  6. Sep 23, 2025InsiderCEO sold ~$1.59M of PATH shares in the open market
  7. Sep 24, 2025InsiderCEO sold ~$1.53M of PATH shares in the open market
  8. Sep 25, 2025InsiderCEO sold ~$1.47M of PATH shares in the open market
  9. Sep 26, 2025InsiderCEO sold ~$1.48M of PATH shares in the open market
  10. Sep 29, 2025InsiderCEO sold ~$1.51M of PATH shares in the open market
  11. Sep 30, 2025InsiderCEO sold ~$1.82M of PATH shares in the open market
  12. Oct 6, 2025Insider · 2 peopleInsiders: 2 sales (~$2.7M)
  13. Oct 7, 2025 · this disclosureInsiderCEO sold ~$1.84M of PATH shares in the open market

What came next

  1. Oct 8, 2025InsiderCEO sold ~$1.83M of PATH shares in the open market
  2. Oct 9, 2025Insider · 2 peopleInsiders: 4 sales (~$6.2M)
  3. Oct 10, 2025InsiderCEO sold ~$2.25M of PATH shares in the open market
  4. Oct 13, 2025Insider · 2 peopleInsiders: 2 sales (~$2.3M)
  5. Oct 14, 2025Insider · 2 peopleInsiders: 2 sales (~$2.2M)
  6. Oct 15, 2025Insider · 3 peopleInsiders: 3 sales (~$2.7M)
  7. Oct 16, 2025Insider · 2 peopleInsiders: 3 sales (~$2.3M)
  8. Oct 17, 2025Insider · 2 peopleInsiders: 2 sales (~$860K)
  9. Oct 20, 2025Insider · 2 peopleInsiders: 2 sales (~$864K)
  10. Oct 21, 2025Insider · 2 peopleInsiders: 2 sales (~$857K)
  11. Oct 22, 2025Insider · 2 peopleInsiders: 2 sales (~$776K)
  12. Oct 23, 2025InsiderCEO sold ~$683K of PATH shares in the open market
  13. Oct 24, 2025InsiderCEO sold ~$696K of PATH shares in the open market
  14. Oct 27, 2025InsiderCEO sold ~$753K of PATH shares in the open market
  15. Oct 28, 2025InsiderCEO sold ~$772K of PATH shares in the open market
  16. Oct 29, 2025InsiderCEO sold ~$733K of PATH shares in the open market
  17. Oct 30, 2025InsiderCEO sold ~$708K of PATH shares in the open market
  18. Oct 31, 2025InsiderCEO sold ~$707K of PATH shares in the open market
  19. Nov 3, 2025InsiderCEO sold ~$730K of PATH shares in the open market
  20. Nov 4, 2025InsiderCEO sold ~$676K of PATH shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for UiPath

For UiPath, OQRO holds 17 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PATH page.

Other recent filings by Daniel Dines, CEO and Chairman

The full history of Daniel Dines, CEO and Chairman is on the profile page.

How this filing works

Explore the data

Common questions

Which UiPath (PATH) insider traded, and how much?

Daniel Dines, CEO at UiPath, sold ~$1.84M of UiPath shares. 123K shares at $14.99.

When did it happen, and when was it made public?

Traded: Oct 7, 2025. Filed: Oct 8, 2025. That is 1 day between the two dates.

What stands out in this filing?

The sale was 12.5% of the shares this insider held before it; the filing reports 859,138 shares, held indirectly afterwards. 122,733 shares at an average of $14.99 each, as reported on the form. Footnote references a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about UiPath recently?

For UiPath, OQRO holds 17 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the PATH page.

Does this mean PATH stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at UiPath

Everything OQRO holds on this company is on its PATH page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data